Laurie Dennison
Family · Granville, NYNPI 1942653852
Payments from drug & device makers
Across 166 payments — averaging $22.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$897
- AbbVie$730
- Lilly USA, LLC$383
- GSK$318
- Johnson & Johnson$311
- AstraZeneca$263
- plus $847 from 19 others
What the payments were for
- Food & beverage$3,750100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 39 | $897 |
| AbbVie | 35 | $730 |
| Lilly USA, LLC | 19 | $383 |
| GSK | 18 | $318 |
| Johnson & Johnson | 8 | $311 |
| AstraZeneca | 7 | $263 |
| Pfizer | 8 | $163 |
| Amgen | 5 | $93 |
| Indivior Inc. | 4 | $84 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| Dexcom, Inc. | 2 | $55 |
| Boehringer Ingelheim | 2 | $46 |
| Merck | 2 | $42 |
| Abbott | 2 | $42 |
| Idorsia Pharmaceuticals US Inc | 2 | $41 |
| Exact Sciences | 1 | $33 |
| Astellas Pharma US Inc | 1 | $30 |
| Boston Scientific | 1 | $23 |
| Amneal Pharmaceuticals LLC | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Vertex | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,750 in reported general payments places this provider in the 90th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 58 | $69,892 |
| MounjaroTirzepatide | 39 | $54,834 |
| TrulicityDulaglutide | 15 | $32,884 |
| OzempicSemaglutide | 29 | $32,401 |
| JardianceEmpagliflozin | 20 | $21,483 |
| ProliaDenosumab | 11 | $18,621 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $15,013 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 63 | $11,087 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $7,565 |
| Humalog Kwikpen U-100Insulin Lispro | 27 | $5,899 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 45 | $5,556 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 100 | $4,045 |
| DexilantDexlansoprazole | 12 | $3,600 |
| Atorvastatin Calcium | 303 | $3,057 |
| Levothyroxine Sodium | 143 | $2,528 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $383 | $87,71854 claims |
| PfizerEliquis | $163 | $69,89258 claims |
| Novo NordiskOzempic | $897 | $32,40129 claims |
| Boehringer IngelheimJardiance | $46 | $21,48320 claims |
| AmgenProlia | $93 | $18,62111 claims |
| GSKTrelegy Ellipta | $318 | $15,01324 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $22 | $2,528143 claims |
| AbbVieSynthroid | $730 | $1,83626 claims |
| Sanofi-aventis U.S. LLCLantus | $18 | $71913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,883 family providers in New York.
Other family in Granville
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
- Sarah AljahmiRockville Centre$87K
- John de OcaStaten Island$86K
- Fara StrickerGlen Oaks$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.